Invitris
ActiveCreating new protein-based drugs at scale
What it does
Invitris radically simplifies how we create novel biological drugs. Our patent-pending technology platform turns DNA into synthetic proteins and was recently featured in the Science magazine. It makes creating new drugs >10,000x more efficient at <100x lower costs of material. Our killer application is enabling the newest generation of synthetic bacteriophages to combat antibiotic-resistant infections, which are threatening to cause more deaths than all cancers combined.
Its site says now · captured 2026-08-23
Invitris - Advancing Biotechnology Research
Invitris is a leading biotechnology company focused on advancing research and development in life sciences and medical technology.
Next to it in Healthcare and bio · synthetic protein drug discovery
- Diffuse BioY Combinator W23
Generative AI for protein design
- AMPLY DiscoveryTechstars TS 2023
AMPLY Discovery — Turning the Dark Genome into Novel Medicines
- Gordion BioscienceTechstars TS 2023
Gordion Bioscience
- FluoSpheraSOSV SOSV IndieBio NY 05
Drug Discovery without animals
- Ångström AIY Combinator S24
Gen AI molecular simulations that reproduce wetlab results
- CellChorusY Combinator S21
The dynamic single-cell analysis company
- CytodymeTechstars TS 2025
Cytodyme
- Elnora AI, Inc.Plug and Play PnP 2025
Elnora is an AI co-pilot for biomedical lab protocols that learns from every experiment to accelerate drug discovery.